Client’s Goals

Our client, one of the key players in the therapeutic apheresis market, engaged MarketsandMarkets to grow revenues. We defined and solved a series of problems for the client. In addition, we offered detailed insights into latent opportunities in the interconnected ecosystems of client’s clients and their clients. Our team helped the client to tap into revenue opportunities in therapeutic apheresis business in Europe. Few of the key problems solved during the engagement are:

• Understanding of the market share of the company
• Insights into the market size of equipment and consumables in terms of value and volume.

Our Approach

We leveraged our AI-driven market intelligence platform, KnowledgeStore, for identifying key growth opportunities of apheresis systems in different application areas in different countries across Europe. Our analysts expanded the understanding of the pricing strategies such as outright sales vs reagent and rental models that were changing the revenue mix of our client’s clients in end-use industries such as hospitals and apheresis units across Europe. We also interviewed various potential customers in these end-use industries to understand their unmet needs, possible use cases. and benefits from these therapeutic apheresis systems and what they looked for in a product partner.

Furthermore, we helped the client to understand the market potential and the impact of use cases of enabling technologies such as centrifugation and membrane across these end-use industries. In addition, our team also helped the client to build an understanding of the competitive landscape, varying business models, and pricing strategies of different players in the therapeutic apheresis market. With these insights, our client services team helped the client to understand their market potential in the therapeutic apheresis market and forge suitable alliances to win the market.

Revenue Shifts Identified

The increasing use of convalescent plasma in treating patients will increase the number of therapeutic apheresis procedures such as plasmapheresis, plasma collection, plasma exchange, thereby increasing the demand for therapeutic apheresis systems and consumables. This will create a shift in the revenues of the company’s in terms of value and volume.

Interconnections

Technological advancements in the field of therapeutic apheresis have resulted in enhanced procedural automation, user-friendly operation, data capturing, and improved patient experience. This is also contributing to effective treatment option for a range of conditions, bringing patients more rapid results and increasing patient comfort.

Unknowns Identified

Therapeutic apheresis for leukaemia and paediatric patients is few of the emerging areas that are expected to offer opportunities to players operating in the therapeutic apheresis market.

Revenue Impact (RI)

Our insights helped the client in identifying new revenue opportunities by tapping into the therapeutic apheresis market across Europe.